The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017
U.S. tax reform: elements of reform already being developed by Congress
The make-up of this tax reform package – to be debated in Congress starting this year and into 2013 – will depend significantly upon the outcome of the November 2012 U.S. elections. There is little doubt, however, given growing bipartisan interest and fiscal pressure, that there will be a significant tax reform package moving in the next Congress.
Our tax policy analysts, including several veterans of the 1986 Tax Reform Act, are already watching and engaged closely in developments in this area. Areas of the tax code most likely to be targeted for change are identified in a recent client alert.
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published guidance for companies submitting a Manufacturing Authorisation application or variation on...06 January 2017
On 16 December 2016, the European Medicines Agency (“EMA”), along with the European Biopharmaceutical Enterprises (“EBE”) organised the fifth annual regulatory...03 January 2017